Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

58-15-1

4-Dimethylaminoantipyrine

58-15-1
1122-58-3

4-Dimethylaminopyridine

1122-58-3
6543-77-7

Doxycycline 4-epi

6543-77-7
4074-88-8

Di(ethylene glycol) diacrylate (stabilized with MEHQ)

4074-88-8
13412-64-1

Dicloxacillin sodium salt monohydrate

13412-64-1
158039-15-7

Desfuroyl Ceftiofur Cysteine Disulfide

158039-15-7
120882-22-6

Desfuroyl Ceftiofur

120882-22-6
NA

Desfuroyl Ceftiofur S-Acetamide HCl

NA
104557-24-6

Desacetyl Cephapirin Sodium Salt

104557-24-6
957-51-7

Diphenamide

957-51-7
548-73-2

Droperidol

548-73-2
75377-45-6

rac N-Desmethyl Tramadol

75377-45-6
144830-15-9

(-)-O-Desmethyl Tramadol

144830-15-9
2922-42-1

3-Dehydroshikimic acid

2922-42-1
2463-84-5

Dicapthon

2463-84-5
963-39-3

Demoxepam

963-39-3
116539-59-4

Duloxetine HCl

116539-59-4
1852-53-5

Dihydroandrosterone

1852-53-5
955-07-7

3,5-Dinitrosalicylhydrazide

955-07-7
3606-45-9

Dihydro sanguinarine

3606-45-9